← Browse by Condition
Medical Condition
glomerulonephritis
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT06889948 Phase 2
Recruiting
The Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland
Enrollment
30 pts
Location
Finland
Sponsor
Helsinki University Central Ho...
NCT05434325
Recruiting
TESTING -ON Post-Trial ObservatioNal Cohort Study
Enrollment
366 pts
Location
Australia, Canada, C...
Sponsor
The George Institute